43 filings
8-K
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
8-K
DAWN
Day One Biopharmaceuticals Inc
12 Jun 24
Regulation FD Disclosure
8:07am
8-K
DAWN
Day One Biopharmaceuticals Inc
30 May 24
Day One Announces Sale of Priority Review Voucher for $108 Million
8:35am
8-K
DAWN
Day One Biopharmaceuticals Inc
24 May 24
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
8-K
jsbsz
24 Apr 24
Regulation FD Disclosure
8:01am
8-K
rti vy2x6yncw5nc
7 Mar 24
Other Events
4:19pm
8-K
wgko1xsu13ed9yjb mcn
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
8-K
fun46 8shh2r9fr1um
17 Jan 24
Day One Announces Two New Appointments to Board of Directors
8:25am
8-K
0y562a
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
n5zz2509myesqnlf x6
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
8-K
unofefkn
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
emyxo
15 Nov 23
Changes in Registrant's Certifying Accountant
4:07pm
8-K
x12ub hqd8
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
uiwgw5kdh6dp739 gegi
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
ux3ow9wr5eaopv4ahanm
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
qlh 4d79hd
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
j9hp390vqmlbv
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
0n1hrk xq
23 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
5qwpy hrm92eqm8a04s
12 Jun 23
Regulation FD Disclosure
8:07am